SRPT Sarepta Therapeutics, Inc.

Pharmaceutical Preparations · Nasdaq · SEC EDGAR official

Market Value*

$1.67B

Revenue (FY)

$1.86B 2025-12-31

Net Income (FY)

$-412.23M

biopharmaceutical company.

Revenue History

*Market value = public float disclosed in latest 10-K filing · CIK 873303 · SEC filings · revenue ranking · home